These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 12162503

  • 1. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
    Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J.
    J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
    [Abstract] [Full Text] [Related]

  • 2. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.
    Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J.
    J Cell Physiol; 2004 Jan; 198(1):155-67. PubMed ID: 14584055
    [Abstract] [Full Text] [Related]

  • 3. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.
    Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J.
    J Cell Physiol; 2000 Jul; 184(1):118-30. PubMed ID: 10825241
    [Abstract] [Full Text] [Related]

  • 4. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility.
    Chellaiah MA, Hruska KA.
    Calcif Tissue Int; 2003 Mar; 72(3):197-205. PubMed ID: 12469249
    [Abstract] [Full Text] [Related]

  • 5. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
    Contractor T, Babiarz B, Kowalski AJ, Rittling SR, Sørensen ES, Denhardt DT.
    In Vivo; 2005 Mar; 19(2):335-41. PubMed ID: 15796195
    [Abstract] [Full Text] [Related]

  • 6. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
    de Vries TJ, Schoenmaker T, Beertsen W, van der Neut R, Everts V.
    J Cell Biochem; 2005 Apr 01; 94(5):954-66. PubMed ID: 15578568
    [Abstract] [Full Text] [Related]

  • 7. Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways.
    Gramoun A, Azizi N, Sodek J, Heersche JN, Nakchbandi I, Manolson MF.
    J Cell Biochem; 2010 Nov 01; 111(4):1020-34. PubMed ID: 20672308
    [Abstract] [Full Text] [Related]

  • 8. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V, Wei H, Ego-Osuala D, Chellaiah MA.
    Exp Cell Res; 2006 Jul 15; 312(12):2214-30. PubMed ID: 16631740
    [Abstract] [Full Text] [Related]

  • 9. Single cell analysis of intracellular osteopontin in osteogenic cultures of fetal rat calvarial cells.
    Zohar R, Lee W, Arora P, Cheifetz S, McCulloch C, Sodek J.
    J Cell Physiol; 1997 Jan 15; 170(1):88-100. PubMed ID: 9012788
    [Abstract] [Full Text] [Related]

  • 10. The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model.
    Caers J, Günthert U, De Raeve H, Van Valckenborgh E, Menu E, Van Riet I, Van Camp B, Vanderkerken K.
    Br J Haematol; 2006 Feb 15; 132(4):469-77. PubMed ID: 16412019
    [Abstract] [Full Text] [Related]

  • 11. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.
    Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T.
    Cancer Res; 1999 Jan 01; 59(1):219-26. PubMed ID: 9892210
    [Abstract] [Full Text] [Related]

  • 12. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
    Teramoto H, Castellone MD, Malek RL, Letwin N, Frank B, Gutkind JS, Lee NH.
    Oncogene; 2005 Jan 13; 24(3):489-501. PubMed ID: 15516973
    [Abstract] [Full Text] [Related]

  • 13. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells.
    Marroquin CE, Downey L, Guo H, Kuo PC.
    Immunol Lett; 2004 Aug 15; 95(1):109-12. PubMed ID: 15325806
    [Abstract] [Full Text] [Related]

  • 14. Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells.
    Atkins K, Berry JE, Zhang WZ, Harris JF, Chambers AF, Simpson RU, Somerman MJ.
    J Cell Physiol; 1998 May 15; 175(2):229-37. PubMed ID: 9525482
    [Abstract] [Full Text] [Related]

  • 15. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.
    Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA.
    Mol Biol Cell; 2003 Jan 15; 14(1):173-89. PubMed ID: 12529435
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of bone sialoprotein mRNA during bone formation and resorption induced by colchicine in rat tibial bone marrow cavity.
    Arai N, Ohya K, Kasugai S, Shimokawa H, Ohida S, Ogura H, Amagasa T.
    J Bone Miner Res; 1995 Aug 15; 10(8):1209-17. PubMed ID: 8585425
    [Abstract] [Full Text] [Related]

  • 18. Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro.
    Kasugai S, Nagata T, Sodek J.
    J Cell Physiol; 1992 Sep 15; 152(3):467-77. PubMed ID: 1510790
    [Abstract] [Full Text] [Related]

  • 19. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia.
    Yan YP, Lang BT, Vemuganti R, Dempsey RJ.
    Neurochem Int; 2009 Dec 15; 55(8):826-32. PubMed ID: 19686792
    [Abstract] [Full Text] [Related]

  • 20. Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro.
    Aitken CJ, Hodge JM, Nicholson GC.
    J Cell Biochem; 2004 Nov 15; 93(5):896-903. PubMed ID: 15389974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.